SS&H Financial Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.55M Buy
+19,871
New +$1.6M 0.4% 56
2025
Q4
$1.72M Buy
17,871
+1,500
+9% +$146K 0.5% 52
2025
Q3
$1.56M Buy
16,371
+10,915
+200% +$1M 0.47% 53
2025
Q2
$476K Buy
5,456
+700
+15% +$59.4K 0.16% 92
2025
Q1
$427K Hold
4,756
0.16% 93
2024
Q4
$380K Hold
4,756
0.14% 103
2024
Q3
$428K Hold
4,756
0.16% 100
2024
Q2
$374K Hold
4,756
0.15% 106
2024
Q1
$414K Hold
4,756
0.17% 96
2023
Q4
$392K Buy
4,756
+2,000
+73% +$152K 0.17% 99
2023
Q3
$216K Buy
+2,756
New +$231K 0.1% 114
2022
Q3
Sell
-2,300
Closed -$206K 117
2022
Q2
$206K Sell
2,300
-400
-15% -$40.5K 0.1% 120
2022
Q1
$300K Buy
+2,700
New +$285K 0.12% 120

Other funds holding MDT

SS&H Financial Advisors's MDT Position: Q2 2026 in Review

SS&H Financial Advisors opened a new position in Medtronic (MDT) in Q2 2026: 19,871 shares worth $1.55M. The stake represents 0.4% of the portfolio and ranks #56 among its holdings. This is a return to the name: SS&H Financial Advisors previously reported a position in MDT as recently as Q4 2025.

SS&H Financial Advisors first reported a position in MDT in Q1 2022 and has held it in 13 quarters since. The position peaked at $1.72M in Q4 2025. 2,135 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • SS&H Financial Advisors held 19,871 shares of Medtronic worth $1.55M as of Q2 2026.
  • Medtronic was a new SS&H Financial Advisors position in Q2 2026.
  • Medtronic made up 0.4% of SS&H Financial Advisors's portfolio in Q2 2026, its #56 holding.
  • SS&H Financial Advisors first reported a position in Medtronic in Q1 2022 and has held it in 13 quarters since.
  • SS&H Financial Advisors's Medtronic position peaked at $1.72M in Q4 2025.
  • 2,135 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on SS&H Financial Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.